Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens

BACKGROUND: Neurocognitive disorders due to human immunodeficiency virus (HIV) remain highly prevalent, specifically mild forms despite effective antiretroviral therapy (ART). Dolutegravir-based regimens are the first line of treatment for adult HIV-positive patients. Controversies exist regarding t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Janine, Lowton, Karishma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546244/
https://www.ncbi.nlm.nih.gov/pubmed/37795459
http://dx.doi.org/10.4102/sajpsychiatry.v29i0.2071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546244/
https://www.ncbi.nlm.nih.gov/pubmed/37795459
http://dx.doi.org/10.4102/sajpsychiatry.v29i0.2071

Ejemplares similares